Patent · US Active

Vaccine for falciparum malaria

US9662379B2 · kind B2 · utility

3Cited by
0References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 30, 2012
Grant dateMay 30, 2017
Priority date—
Expiry dateNov 30, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for preventing or reducing the severity of malaria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.